Luminex's Q1 Revenues up 30 Percent | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Luminex today said its first-quarter revenues spiked 30 percent year over year, led by record consumables sales.

The Austin, Texas-based molecular diagnostics and multiplex test technologies firm said that revenues rose to $43.3 million for the three months ended March 31, compared to $33.3 million in the first quarter of 2010, exceeding Wall Street expectations of $39.9 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.